EMEA-001497-PIP01-13 - paediatric investigation plan

perindopril

bisoprolol

Key facts

• Active substance:
  • perindopril
  • bisoprolol
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/0213/2014
• PIP number:
  EMEA-001497-PIP01-13
• Pharmaceutical form(s):
  Tablet
• Condition(s) / indication(s):
  • Treatment of heart failure
  • Treatment of hypertension
  • Treatment of ischaemic coronary artery disorders
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  01/09/2014
• Compliance check done:
  No

Decision

P/0213/2014: EMA decision of 1 September 2014 on the granting of a product specific waiver for perindopril / bisoprolol (EMEA-001497-PIP01-13)

Adopted Reference Number: EMA/467314/2014